FDA Approves New T2 Diabetes Drug: Alogliptin

It’s a DPP-4 inhibitor, a class with three other drugs in the U.S.  The brand name in the U.S. is Nesina.  It can be used with other drugs such as metformin and pioglitazone.  The FDA’s press release of Jan. 25 has a little more info.